Beam Therapeutics Inc (BEAM)vsRevolution Medicines Inc (RVMD)
BEAM
Beam Therapeutics Inc
$23.99
-1.56%
HEALTHCARE · Cap: $2.60B
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Beam Therapeutics Inc generates 20929% more annual revenue ($156.03M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -55.4%. BEAM earns a higher WallStSmart Score of 25/100 (F).
BEAM
Avoid25
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
ROE of -5.8% — below average capital efficiency
Revenue declined 94.2%
Negative free cash flow — burning cash
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : BEAM
The strongest argument for BEAM centers on Debt/Equity, Price/Book.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : BEAM
The primary concerns for BEAM are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
BEAM profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
BEAM carries more volatility with a beta of 2.23 — expect wider price swings.
BEAM is growing revenue faster at -94.2% — sustainability is the question.
BEAM generates stronger free cash flow (-69M), providing more financial flexibility.
Bottom Line
BEAM scores higher overall (25/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Beam Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?